Karin Bolstad

Functional and Specific Antibody Responses in Adult Volunteers in New Zealand Who Were Given One of Two Different Meningococcal Serogroup B Outer Membrane Vesicle Vaccines

Elisabeth Wedege, Karin Bolstad, Audun Aase et al. · Clinical and Vaccine Immunology · 2007 · 54 citations · Full text

Vaccination, Mucosal Vaccination, Vaccine Development +13

Characterization of meningococcal serogroup B outer membrane vesicle vaccines from strain 44/76 after growth in different media

Nikos Tsolakos, Kristian Lie, Karin Bolstad et al. · Vaccine · 2010 · 34 citations

Vaccination, Vaccine Target, Pathogenesis +10

Protection by Natural Human Immunoglobulin M Antibody to Meningococcal Serogroup B Capsular Polysaccharide in the Infant Rat Protection Assay Is Independent of Complement-Mediated Bacterial Lysis

Maija Toropainen, Leena Saarinen, Elisabeth Wedege et al. · Infection and Immunity · 2005 · 26 citations · Full text

Pathogenesis, Immunology, Complement-mediated Bacterial Lysis +11

Antibody Specificities and Effect of Meningococcal Carriage in Icelandic Teenagers Receiving the Norwegian Serogroup B Outer Membrane Vesicle Vaccine

Elisabeth Wedege, Betsy Kuipers, Karin Bolstad et al. · Infection and Immunity · 2003 · 23 citations · Full text

Vaccination, Mucosal Vaccination, Meningococcal Carriage +13

Preclinical immunogenicity and functional activity studies of an A+W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccines

Gro Tunheim, Marianne Arnemo, Lisbeth Meyer Næss et al. · Vaccine · 2013 · 17 citations

Vaccination, Meningococcal Conjugate-, Mucosal Vaccination +11